Research and development (R&D) costs incurred by pharmaceutical majors remained at blockbuster level in 2016, but very few blockbuster drugs were brought to market, says a report by Deloitte using...
22 December 2016
8 December 2016
The global market for neurodegenerative drugs is projected to grow from $27.2bn in 2015 to $45bn by 2022, according to a report by GBI Research.
1 December 2016
The pharmaceutical market in Israel is projected to grow from $1.75bn in 2015 to $2.12bn by 2020, at a compound annual growth rate (CAGR) of 3.9%, says a report by...
24 November 2016
The non-small-cell lung cancer (NSCLC) market is anticipated to increase from $6.21bn in 2015 to $26.71bn by 2025, according to a report by GlobalData.
17 November 2016
The myelofibrosis market is projected to increase from $545.2m last year to $1.02bn by 2025, according to a report by GlobalData.
10 November 2016
The schizophrenia market is projected to increase from $6.4bn in 2015 to $7.3bn by 2025 at a compound annual growth rate of 1.4%, according to a report by GlobalData.
27 October 2016
Report: Quadrivalent vaccines and rising immunisation recommendations to drive growth of seasonal influenza vaccines
Developed nations expanding vaccination recommendations against seasonal influenza and growth of egg-based quadrivalent seasonal influenza vaccines are expected to increase growth of the seasonal influenza vaccine market, says a report...